News on CML - Archives 2013-2012 - Chronic myeloid leukemia
Remembering Dr. John Goldman
December 27, 2013, ICMLf
ASH Report #2: First-line trial updates, STOP trials, early switching, comorbidities, side effects
December 27, 2013, CML advocates network
Top Clinical Cancer Advances: ASCO 2013 Report. Two new drugs were approved for chronic myeloid leukemia (Omacetaxine mepesuccinate (Synribo), Ponatinib (Iclusig) )
December 26, 2013, Medscape
Professor John M Goldman Past away this afternoon
December 24, 2013, cmlsupport
Dr. Shapiro Discusses Bosutinib in CML VIDEO
December 23, 2013, OncLIve
The Changing CML Treatment Landscape (Dr. Jessica Altman) VIDEO
December 20, 2013, Patient Power
Off and On Again Story of Ponatinib in CML – by Michael Deininger, reporting from ASH 2013
December 20, 2013, Medscape
After Brief Halt, FDA Allows Sales of Drug for Cancer to Resume
December 20, 2013, New York Times
Memorial Sloan-Kettering Mourns the Death of Cancer Research Pioneer Janet Rowley
December 20, 2013, Memorial Sloan-Kettering Cancer Center
OncoBlog: Driving the CAR to a Cancer Cure?
December 19, 2013, MedPage Today
Janet Rowley dies at 88; scientist pinpointed genetic cause of leukemia
December 19, 2013, Los Angeles Times
How Gleevec Changed the Game for Novartis
December 18, 2013, The Motley fool
Ariad Pharmaceuticals - Positive News From Regulators
December 18, 2013, Seeking Alpha
Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and
other tyrosine kinase inhibitors
December 17, 2013, Journal Blood
Preclinical data shows BGB324 as potential treatment option for Chronic Myeloid Leukemia
December 17, 2013, News medical
Study identifies reasons for CML non-adherence
December 16, 2013, ecancernews
Cancer as a metabolic disease: implications for novel therapeutics
December 16, 2013, NCBI
Persistent patient: Man earns diploma after fight with leukemia
December 15, 2013, Joplin Globe
Dasatinib+letrozole improves survival for women with hormone receptor-positive, HER2-negative metastatic breast cancer
December 13, 2013, News Medical
Drug Combo Delayed Progression in Some Metastatic Breast Cancer Patients
December 13, 2013, Cancer Network
Genetic Puzzle Piece for Blood Cancers Found
December 12, 2013, MedPage Today
Dasatinib Added to Aromatase Inhibitor Extends PFS in HER2-Negative MBC
December 12, 2013, OncLive
Bristol-Myers Presents Long-term Data on Sprycel - Analyst Blog
December 10, 2013, NASDAQ
Phase III studies demonstrate superiority of Novartis' Tasigna over Glivec in newly diagnosed Ph+ CML patients
December 10, 2013, Pharmabiz.com
Preliminary Results from Bio-Path Holdings’ Phase I Clinical Trial Presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans
December 9, 2013, Business Wire
ARIAD Loses as EMA Deliberates on Iclusig - Analyst Blog
December 9, 2013, Zacks.com,
Four-Year Data from Phase 3 DASISION Trial Comparing Sprycel® (dasatinib) to Imatinib in First-Line Treatment of Adults with Ph+ CP-CML Presented at ASH 2013
December 9, 2013, Business Wire
Excitement Over CAR-Engineered T-cells in Leukemia and Lymphoma
December 9, 2013, Medscape
Novartis: Data Support Superiority Of Tasigna Over Glivec
December 9, 2013, RTT News
Why Observing Treatment Milestones is an Individual Decision
December 8, 2013, Curetoday.com
Penn Medicine Team Reports Findings from Research Study of First 59 Adult and Pediatric Leukemia Patients Who Received Investigational, Personalized Cellular Therapy CTL019
December 7, 2013, Penn Médicine
Gene therapy scores big wins against blood cancers VIDEO
December 7, 2013, CBSNews
EU Starts In-Depth Review of Troubled Leukemia Drug
December 6, 2013, Medscape
Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly
diagnosed chronic myeloid leukemia in chronic phase
December 2013, DocGuide.com
Six Common Misconceptions about the Chronically Ill
December 5, 2013, Psychology Today
Why Are Cancer Drugs Commonly The Target Of Schemes To Extend Patent Exclusivity?
December 4, 2013, Health Affairs
Researcher seeks to identify the pathway that leads to cells forming into an individual body
December 3, 2013, National Science Foundation
Alston Wins Comeback Player of Year
December 2, 2013, New England Soccer Today
Glivec Generics May Be Delayed In The U.S. - Buy Novartis
December 2, 2013, Seeking Alpha
Revs' Kevin Alston wins MLS Comeback Player of the Year
December 2, 2013, Boston Herald
Researchers developing DNA test for tainted pot
December 2, 2013, natmonitor.com
Fund-raising event in Madison offers trips to Alaska, Grammys, New York
November 29, 2013, New Jersey Hills
Negative NICE appraisal of Pfizer's Bosulif for CML
November 27, 2013, The Pharma Letter
Study: Women With Allergies Have Increased Blood Cancer Risk
November 26, 2013, Cancer Network
FDA Cancer Czar Floats Change to Drug Review Process
November 26, 2013, Scientific American
Advocates Lobby for Continued Access to Ponatinib in US
November 26, 2013, Medscape
Patients' advocates press FDA to retain lifesaving drugs (Iclusig)
November 24, 2013, Boston Globe
Leukemia patient’s last resort is bone marrow transplant
November 25, 2013, BangaloreMirror
FDA Tells Google-Backed 23andMe to Halt DNA Test Service
November 25, 2013, Bloomberg
Ariad jumps on European drug action
November 23, 2013, Boston Globe
Waterloo girl receives trip of a lifetime
November 21, 2013, hngnews.com
Ponatinib demonstrated activity in patients with CML, Ph+ALL
November 21, 2013, HemOnctoday
Inhibition Of RNA Polymerase I Transcription By CX-5461 As a Therapeutic Strategy For The Cancer-Specific Activation Of p53 In Highly Refractory Haematological Malignancies
November 15, 2013, Journal Blood
San Francisco turns into Gotham City for Batkid (5-year-old with leukemia )
November 15, 2013, Daily News
Cancer diversity has 'huge implications'
November 15, 2013, News Health
Monitoring treatment response is crucial in leukemia management
November 15,2013, Inquirer.net
Improving access to leukemia treatments
November 15,2013, Inquirer.net
Madison based fund-raising event offers trips to Alaska, Grammys, New York
November 15, 2013, New Jersey Hills
Ariad Pharmaceuticals unveils plan to conserve cash
November 12, 2013, Boston Globe
More on Ponatinib and Next Steps - Harry Erba, MD VIDEO
November 7, 2013, NationalCMLSociety
Market Removal of Ponatinib Raises Questions, concerns
November 7, 2013, Medscape
Interaction Between Two Leukemia Drugs Explained
November 5, 2013, Science Daily
Considerations for Patients Taking Ponatinib - Michael Mauro, MD VIDEO
November 5, 2013, NationalCMLSociety
Boston Marathon survivor Dave Fortier won't forget the bombing victims when he races to the finish in New York
November 2, 2013, Daily News
FDA Asks for Halt in Sales of Blood Cancer Rx
November 1, 2013, dailyRx
Doctors Fear Losing Leukemia Drug Deemed Risky
November 1, 2013, New York Times
Serious Danger of Blood Clots Halts Sale of Leukemia Drug
October 31, 2013, New York Times
Genetic details of leukemia resistance
October 31, 2013, Oncology Nurse Advisor
Ariad Pharmaceuticals, Inc. (ARIA): Ariad Is Rising With Catalysts Approaching
October 31, 2013, Seeking Alpha
Unique Considerations With TKIs for Chronic Myelogenous Leukemia
October 25, 2013, OncLive
Morningside's Granatowicz battles back from cancer
October 24, 2013, JournalStar.com
The Cost of Living - New drugs could extend cancer patients’ lives
October 20, 2013, New York News& Politics
Late-Stage Ponatinib Study Discontinued
October 18, 2013, OncLive
Ariad Halts Iclusig Trial; Shares Plunge Over 38%
Oct 18, 2013, NASDAQ
Ariad Stops Phase 3 Epic Trial Of Iclusig In Patients With Newly Diagnosed CML
October 18, 2013, RTT News
Ariad crushed (again) after PhIII Iclusig trial is shuttered on blood clot fears
October 18, 2013, FierceBiotech
This Amino Acid Reverses Nerve Damage
October 15, 2013, institutefornaturalhealing.com
Some Cancer Patients May Overdo Oral Meds
October 13, 2013, MedPage Today
Taubman Institute gives $100K grant to cancer scientists
October 12, 2013 The Michigan Daily
Blood Clots in Trial Prompt FDA Alert on Iclusig
October 11, 2013, Medpage Today
Inclusig (Ponatinib): Drug Safety Communication - Increased Reports Of Serious Blood Clots In Arteries And Veins
October 11, 2013, FDA
Ariad's Nasty Surprise Gives The Sellside Pause For Thought
October 9, 2013, Seeking Alpha
Safety Concerns Halt Ponatinib Development
October 9, 2013, Onc LIve
DelMar Pharma talks to Life Sciences IP Review (LSIPR) about creating new patents for shelved drugs to streamline path
to patients
October 9, 2013, PR Newswire
Novartis A.G. V Union of India - The Gleevec Case and Evergreening
October 8 2013, Lexocology
Verastem Targets Cancer Stem Cells
October 8, 2013, Onc LIve
Going the extra mile to honor a Griffin Hospital volunteer
October 8, 2013, Shelton Herald
Two Mutations Help Leukemia Escape Drugs
October 7, 2013, Drug Discovery Development
Battling defiant leukemia cells
October 7, 2013, EurekAlert
Bone Marrow Transplant - a Donation That Saves a Life
October 7, 2013, AllAfrica.com
Improving access to leukemia treatments
October 4, 2013, Philippine Daily Inquirer
Madison to walk against cancer Sunday
October 2, 2013, New Jersey Hills
"Jump in For a Cure" Raises Funds for The Leukemia and Lymphoma Society
September 29, 2013, PotageLife.com
World Chronic Myeloid Leukemia Day: ‘Leukemia common among younger Pakistanis’
September 27, 2013, The Express Tribune
JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia
September 26, 2013, Journal Blood
With $1 billion hanging in the balance, Knight Cancer Institute must show its best nationwide
September 24, 2013, Oregon Live
Targeted drugs extend cancer patients’ lives
September 23, 2013, Taipei Times
Novartis progresses with clinical trials in chronic myeloid leukemia
September 19, 2013, ThePharmaLetter
Ariad Pharma: Dismantling The Short Thesis
September 19, 2013, TheStreet.com
Hallmarks of Cancer 1: Self-Sufficiency in Growth Signals
September 18, 2013, Scientific American
Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase
September 17, 2013, Pediatric Blood & Cancer
Dr. Druker, Reps. Capps and King to Receive AACI Awards
September 16, 2013, Newswise
Immune system marker tied to improved bone marrow transplant outcomes
September 16, 2013, HealthCanal.com
ARIAD is leasing more space at new Kendall Square facility, Alexandria says
September 16, 2013, Boston.com
Oral Oncolytics: Part 2—Legislation Targeting Cost & Access, and Other Initiatives to Reduce Costs
September 15, 2013, Cancer Network
Trial Suggests Imatinib Discontinuation Safe, Some Responses Persist
September 15, 2013, Cancer Network
'Bristol-Myers misleading HC in patent case'
September 14, 2013, Times of India
Dasatinib Shows Promise for Pediatric CML, ALL Patients
September 13, 2013, Cancer Network
Interesting turn in Dasatinib patent war
September 12, 2013, Times of India
Conneaut eighth grader conquers childhood cancer
September 12, 2013, The Star Beacon
BDR Pharmaceutical's plea for compulsory licence on cancer drug rejected
September 12, 2013, The Economic Times
Panel backs compulsory licence on cancer drug
September 11, 2013, Livemint
Novartis Ties Up With Regenerex
September 10, 2013, Zacks
Rare, Inherited Mutation Leaves Children Susceptible to Acute Lymphoblastic Leukemia
September 9, 2013, Science Daily
Generic cancer drug - access not guaranteed
September 9, 2013, Mail Guardian
GALLAGHER: Year after tackling leukemia, Morningside linebacker returns to field in Sioux City
September 8, 2013, Sioux City Journal.com
Madison Superintendent Rossi to be honored at Martell walkathon
September 6, 2013, New Jersey Hills
ARIAD enrolls 50% of patient planned in phase III EPIC trial of Iclusig
September 6, 2013, Pharmabiz.com
Impressive thrombocytosis evolving in a patient with a BCR-ABL positive CML in major molecular response during dasatinib
treatment unmasks an additional JAK2V617F
September 5, 2013, Experimental Hematology & Oncology
Otsuka to buy cancer biopharma Astex
September 5, 2013, PMLive
New Strategy Against High-Risk Leukemia
August 29, 2013, Science Daily
Anthony Pawson, Biologist in Cell-Protein Breakthrough, Dies at 60
August 29, 2013 , New York Times
Study yields new strategy against high-risk leukemia
August 29, 2013, Medical Xpress
Chronic Myelogenous Leukemia: Anchoring ABL for a Better Fate
August 27, 2013, Science Daily
Anchoring ABL for a better fate
August 27, 2013, Medical Xpress
Martell Foundation seeks walkathon volunteers in Madison
August 23, 2013, Madison Eagle
Ruxolitinib Plus Capecitabine Improves Survival in Pancreatic Cancer
August 21, 2013, OncLive
The treatment: Improving on success
Summer 2013, MD Anderson Cancer Center
The Philadelphia Chromosome: A Mutant Gene and the Quest to Cure Cancer at the Genetic Level’ by Jessica Wapner
August 16, 2013, The Washington Post
Dr. Anton Bilchik Discusses New Cancer Treatments
August 16, 2013, Prleap
First-Line Treatment for Patients With CML in Chronic Phase: Why Imatinib Is an Appropriate Choice
August 15, 2013, Cancer Network
Ottawa researchers hopeful nano-particles can cure leukemia
August 13, 2013, CTV News
ASCO 2013: Humanity Meets Immunity
August 13, 2013, OncLIve
Tony Pawson, internationally acclaimed Canadian scientist, dies at 60
August 9, 2013, The Globe and Mail
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
August 8, 2013, Journal Blood
Jerry Mayfield – Lost of a CML warrior
August 8, 2013, NationalCmlSociety
Ponatinib—A Step Forward in Overcoming Resistance in Chronic Myeloid Leukemia
August 5, 2013, Clinical cancer Research
Measuring the symptom burden associated with the treatment of chronic myeloid leukemia
August 1, 2013, Journal Blood
What challenges remain in chronic myeloid leukemia research?
August 1, 2013, Haematologica
Routine Monitoring for MRD in Leukemia? It's Coming
August 1, 2013, Medscape,
Has Carl June Found a Key to Fighting Cancer?
August 2013, The Phillymag.com
WATCH: Pro Wakeboarder Fights Chronic Myeloid Leukemia Daily to Reach Goals
July 31, 2013, Huffington Post
Perspective: Combined forces
June 27, 2013, Nature
Derby organizers pay tribute to long-time drivers at fair
July 26, 2013, Journal News
Effects of food on the pharmacokinetics of ponatinib in healthy subjects.
July 25, 2013, PublMed
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease:
results from the TWISTER study
July 25, 2013, Journal Blood
State of CML Treatments
July 25, 2013, CancerNetwork
5-year-old cancer patient receives new playground
July 25, 2013, DailyPress
Eugene Jeans Guy Upbeat Despite Cancer
July 25, 2013, EugeneWeekly.com
Kids with cancer: Part III: You can help raise money to find a cure
July 23, 2013, SyracuseParent.net
Royal Society accolades for Manchester scientists - GlaxoSmithKline Prize. Dr Nicholas Lydon
July 22, 2013, University of Manchester
Kevin Alston, treated for leukemia, talks about New England Revolution return VIDEO
Jul 17, 2013, ProSoccerWalk
Kevin Alston back on the Revolution roster
July 17, 2013, Boston Globe
Novartis 2nd-quarter in line with analysts' forecasts
July 17, 2013, The Pharma Letter
Negative NICE news for Pfizer leukemia drug
July 16, 2013, The Pharma Letter
Northfielder credits blood donation with early cancer diagnosis
July 16, 2013, Northfield News
Homoharringtonine Induction Therapy for Treatment-Naïve AML
July 2013, Clinical Oncology News
TWIST it but don’t spin it
July 25, 2013, Journal Blood
Pfizer faces NICE rejection for cancer drug Bosulif
July 16, 2013, PMLiVE
Where Next for TKIs in CML? EHA Data and Expert Opinion
July 15, 2013, Medscape
Recently Released Market Study: PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market
Analysis to 2022
July 15, 2013, SBWire
EUTOS Score Validated for Predicting Treatment Outcomes With TKI Therapy
July 12, 2013, Cancer Network
Martell Foundation seeks Madison walkathon volunteers
July 11, 2013, New Jersey Hills
Recently Released Market Study: Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
July 11, 2013, SBWire
Ponatinib Receives Marketing Authorization in Europe for CML and Ph+ ALL
July 11, 2013, Cancer Network
Developing Novel Treatments Using the AML Genome
July 10, 2013, Cancer Network
Project fights cancer with satin and lace
July 9, 2013. USA TODAY
A Battle Against Wayward Genes
July 4, 2013, The Wall Street Jounal
New Market Research Report: PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain Drug Forecast and Market
Analysis to 2022
July 4, 2013, SBWire
My Survivor Story: Mark Popadick, Chronic Myelogenous Leukemia Survivor VIDEO
July 2, 2013, Memorial Sloan-Kettering
ARIAD Announces Marketing Authorization for Iclusig® (ponatinib) in the European Union
July 2, 2013, Daily Finance
World War Cancer
July 1, 2013, The New Yorker
QOL issues affect patients with CML taking oral chemotherapy
July 1, 2013, Oncology Nurse Advisor
wo CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate.
June 2013, PublMed
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
June 26, 2013, PublMed
No More Chemo: Doctors Say It’s Not So Far-Fetched
June 26, 2013, Time Health & Family
FDA Updates Dasatinib Label for Chronic Myeloid Leukemia
Jun 26, 2013, Medscape
BCR-ABL1 kinase domain mutations may persist at very low levels for many years and lead to subsequent TKI resistance.
June 25, 2013, PublMed
Bristol-Myers Squibb gets a boost for leukemia drug Sprycel
June 21, 2013, FiercePharma
New Follow-Up Data for Sprycel Among the Longest for CML
June 21, 2013, MPR
Tools& Techniques: Quantum Dot-based microRNA Detection; siRNA Delivery to Leukemia Cells; and More
June 20, 2013, Genome Web
TKI Therapy Affects Quality of Life in CML Patients
Jun 20, 2013, Medscape
Cancer Risk From CT Scan Radiation VIDEO
June 19, 2013, NutritionFacts.org·
New Market Report: PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
June 17, 2013, SBWire
Imatinib Discontinuation in Chronic Phase CML Doesn’t Always Lead to Relapse
June 14, 2013, Cancer Network
Intermittent Imatinib for Elderly CML Patients Shows Promise
June 14, 2013, Cancer Network
Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
June 13, 2013, Hindawi
Curing Cancer: The Philadelphia Award and Dr. Carl June VIDEO
June 11, 2013, Rich Tolsma Productions
Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early
treatment modifications in suboptimal responders: A retrospective study on 91 unselected patients.
June 11, 2013, PublMed
Quality-of-life issues need to be addressed for CML patients, Moffitt researchers say
June 10, 2013, Science Codex
Quality-of-life issues need to be addressed for CML patients, researchers say
June 10, 2013, MedicalXpress
Targeted cancer therapy pioneers tapped to receive the 2013 $100,000 Taubman Prize
June 5, 2013, PRNewswire
Research and Markets: Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
June 5, 2013, Fort Mills Times
New Drug Target Identified For Treating Deadly Form Of Leukemia
June 4, 2013, AsianScientist
Singapore research team identifies new drug target in deadly form of leukemia
June 3, 2013, EurekAlert
Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers
at ASCO and EHA
May 29, 2013, FierceBiotech
The BCR-ABL T315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to
tyrosine kinase inhibitors, in a matched pair analysis
May 28, 2013, Haematologica
American Cancer Society Legends: Dr. Brian Druker VIDEO
May 28, 2013, American Cancer Society
Going one-on-one with Kareem Abdul-Jabbar
May 28, 2013, Bay Area, Biz Talk
Revs, fan group to hold trivia night in support of Alston and his leukemia battle
May 28, 2013, Boston.com
Run4Beka raising funds for cancer group
May 28, 2013, Santa Ynez Vallez News
Revolution, Fans To Hold Trivia Night Fundraiser in Support of Kevin Alston, Leukemia and Lymphoma Society on May 30
May 26, 2013, NESN
Skyhook king, Abdul-Jabbar, in town to support leukemia fight
May 25, 2013, San Jose Mercury News
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER Study
May 23, 2013, PublMed
Man's dream of marriage comes true even as he fights cancer
May 22, 2013, WDRB.com
Bankruptcy or Cure? A Cancer Patient's Dilemma
May 22, 2013, Medscape Today
Ariad's Cancer Drug Iclusig Extends The Gleevec Magic
May 22 2013, Seeking Alpha
Teen Develops Computer Algorithm to Diagnose Leukemia
May 21, 2013, Mashable
18-yr-old teaches computer to diagnose cancer
May 21, 2013, rappler.com
Dawn Tyler Watson headlines all-star Blues for Life concert to benefit leukemia survivors
May 21, 2013, Montreal Gazette
New leukemia mutation offers therapeutic targets
May 21, 2013, 2 minutes medicine
QuantuMDx, A*STAR To Develop Asia-Specific Genetic Tests
May 21, 2013, Asian Scientist
CML Drug Revenue in Japan to Grow, Despite Global Decline
May 20 2013, Pharmiweb.com
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
May 19, 2013, Motley Fool
Cancer Drug Prevents Build-up of Toxic Brain Protein
May 16, 2013, HealthCanal.com
Woman with leukemia meets researchers of her life-saving drug
May 16, 2013 , UPI.com
The cost of my cancer survival
May 16, 2013, timesunion.com
How I Manage: Chronic Myeloid Leukemia
May 2013, Clinical Oncology News
Faith, family help Brooks fight leukemia
May 16, 2013, ThisWeekNews
Discovery pinpoints cause of two types of leukemia, providing insights into new treatment approach
May 14, 2013, HeathCanal
Nilotinib Associated With Increased Peripheral Artery Disease Rate in CML
May 13, 2013, Cancer Network
Mice Study Finds Cancer Drug May Work on Common Brain Diseases
May 13, 2013 PsychCentral.com
Direct hit on cancer
May 12, 2013, New York Post
Targeting of the MNK–eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function
May 10, 2013, PNAS
Mouse study shows leukemia halts accumulation of toxic proteins linked to Parkinson's disease
May 10, 2013, News Medical
Cancer treatments "unaffordable" and will drive rapid transition to generics and market decline, says GlobalData
May 10, 2013, the pharmaletter
The Story Behind a Miracle Cancer Drug [Excerpt]
May 10, 2013, Scientific American
Discovery pinpoints cause of two types of leukemia - Science Daily
May 10, 2013, Science Daily
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib
discontinuation in patients with CML
May 9, 2013, PublMed
Mutations in CSF3R common in CNL, atypical CML - Medical Xpress
May 9, 2013, Medical Xpress
New leukemia mutation offers therapeutic targets
May 8, 2013, 2 minutes medicine
Do Blood Cancers Need Prophylactic Platelet Transfusions? - Medscape
May 8, 2013, Medscape
High costs of leukemia may be harming patients
May 7, 2013, Oncology Nurse Advisor
The Model Approach to Drug Development
May 6, 2013, Bio It World
Ruling thrills patients and boosts Indian generic drug makers
May 6, 2013, Smart Planet
Pharmaceutical Companies Profits Reach 30 Percent, Author Says
May 3, 2013, The Lund Report
LLS - Brian Druker, MD
May 2, 2013, LeukemiaLymphomaSoc·
News from the Front in War on Cancer--Mission Not Accomplished
May 2, 2013, , Scientiific American
Are CML Drugs Priced Out of Reach?
May 2, 2013, Cancer Network
News from the Front in War on Cancer--Mission Not Accomplished
May 2, 2013, Yahoo! News
Essential profits vs. medical profiteering
May 1, 2013, Journal Inquirer
The Beginning of the End of the Beginning in Cancer Genomics
May 1, 2013, The New England Journal of Medicine
Genomic Mutation Studies Unlock Details on Cancers
May 1, 2013, The Wall Street Journal
Exorbitant Prices for Leukemia Drugs
May 1, 2013, New York Times
PITTS: When generics win, patients lose
May 1, 2013, Washington Times
Ponatinib Excels in Heavily Pretreated Population
April 2013, Clinical Oncology News
The real cancer killer: rip-off prices for drugs
April 29, 2013, The independent
Drug industry 'profiteering' threatens lives
April 29, 2013, News Mail
Leukaemia drug prices "unsustainable" say cancer experts
April 29, 2013, PMLive
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013
April 29, 2013, Seeking Alpha
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid
leukemia resistant or intolerant to imatinib.
April 28, 2013, Publmed
How Much Is Your Life Worth? - San Diego Free Press
April 28, 2013, San Diego Free Press
Doctors around the world criticize drug companies for high cost of life-saving pills
April 27, 2013, abc action news
Lifestyle and Dietary Factors in Relation to Risk of Chronic Myeloid Leukemia in the NIH-AARP Diet and Health Study
April 26, 2013, Publmed
Doctors blast ethics of $100000 cancer drugs
April 26, 2013, CNNMoney
Are $100000 cancer drugs unethical?
April 26, 2013, The week
Top Oregon Health & Science University researcher to doctors: Rise up over drug prices
April 25, 2013, OregonLive
Cancer Doctors Raise Pressure On Pharma Industry To Cut Drug Prices
April 25, 2013, Forbes
Leading leukemia experts: High leukemia treatment costs may be harming patients
April 25, 2013, Eurekalert
DelMar IPO Obscurity Could Offer Investors Favorable Entry
April 24, 2013, Seeking Alpha
Lehigh Valley students take top honors at regional research event
April 23, 2013, Penn State News
A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia
April 22, 2013, PubLMed
Hope for Karen wrestling benefit in Millersville Friday
April 22, 2013, Examiner.com
Vanderbilt Patients Collaborate With Nashville’s Music Row Superstars To Bring Their Songs To Life
April 22, 2013, Newswise
In a first, Rajasthan govt to provide free leukemia drugs
April 21, 2013, Times of India
Landmark verdict
April 20, 2013, Frontline
Novartis Indian Supreme Court judgment: what is efficacy for pharmaceutical invention?
April 19 2013, Lexocology
What Makes a Good Founder? Hint: it's in the details
April 19, 2013 , Forbes
More research needed on causes of leukemia, as growing lifespan of patients enables study, says GlobalData
April 18, 2013, the pharmaletter
Janet Rowley shares prestigious medical prize with cancer treatment pioneers
April 17, 2013, UChicagoNews
New Mechanism of Resistance Identified in Brain Tumors
April 17, 2013, OncLive
C. William Johnson, band director
April 17, 2013, Washington Post
Long-Term Treatment With Imatinib Affected Bone Mineral Density
April 16, 2013, CancerNetwork
Chronic Fatigue Limits Quality of Life in Imatinib-Treated CML Patients
April 16, 2013, Cancer Network
Long-Term Treatment With Imatinib Affected Bone Mineral Density
April 15, 2013, Cancer Network
AVEO Poised To Move Higher Before May 2 FDA Adcomm Catalyst, Obama Care, And Platform Potential
April 15, 2013, Trefis
A dose of transparency
April 15, 2013, The Indian Express
Pharmaceutical companies must balance profits and affordability
April 14, 2013, The New Indian Express
TASIGNA (nilotinib) - Possible Risk of Developing Atherosclerosis-Related Conditions - For the Public
April 12, 2013, Health Canada
Glasford inspires runners, donors to join fight against blood cancer
April 12, 2013, NCNewsPress.com
Nilotinib for CML Leads to Fewer Treatment-Emergent Mutations Than Imatinib
April 12, 2013, Cancer Network
Patients or patents?
Apr 12, 2013. Livemint
Teenager dies of leukaemia ten days after tonsillitis diagnosis
April 11, 2013, Metro
Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in India
April 10, 2013, The Atlantic
Drug sales reps often don't inform docs about adverse effects: Study
April 10, 2013, lfpress.com
The Cost of Cancer Drugs and Research
April 9, 2013, Huffpost Healthy Living
Prof. Levitzki chosen for American Cancer Research Award
April 9, 2013, IsraelNationalNews
ARIAD Pharmaceuticals presents preclinical data on ponatinib at AACR Annual Meeting 2013
April 9, 2013, NewsMedical
ARIAD’s leukemia drug Iclusig may be used in other cancer treatments
April 8, 2013, bioflash
New England Revolution defender Kevin Alston diagnosed with treatable form of leukemia
April 8, 2013, MLSsoccer.com
HU biochemistry professor to receive major award
April 7, 2013, Jerusalem Post
Dr. Hagop Kantarjian Receives the 18th Annual AACR Joseph H. Burchenal Memorial Award
April 6, 2013, American Association for Cancer Research
CML-Living with a Chronic Disease
April 5, 2013, PRNewswire
Novartis Loses Historic India Patent Case On Cancer Drug Glivec
April 5, 2013, Asian Scientist
Conditional EU Approval for Pfizer's Bosulif - Analyst Blog
April 4, 2013, NASDAQ
ARIAD's CEO fights back, defends leukemia drug despite report
April 4, 2013, Boston Business Journal
A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research
April 4, 2013, News Maker
The Philadelphia chromosome
April 4 2013, live mint
Ariad's Leukemia Drug Toxic, Survey Says
April 3, 2013m, The Street
Dr. Alex Matter Awarded 2013 Szent-Györgyi Prize For Progress In Cancer Research
April 3, 2013, Asian Scientist
Guest Post: The Patent Failure of Novartis with Gleevec
April 3, 2013, Patenty O.
Father of Glivec hails SC ruling
April 3, 2013, The Times of India
‘Deterred by cost of Glivec, many embraced death’
April 3, 2013, The New Indian Express
Promising stem cell therapy for leukemia patients
April 2, 2013, MedicalXpress
Supreme Court's Glivec ruling will ruin innovation, says Ranjit Shahani, Novartis India MD
April 2, 2013, The Economic Times
Don't cut lifesaving dollars - Health research and medical progress are in peril amid NIH budget cuts
April 2, 2013, Los Angeles Times
Glivec ruling: Putting patients before profits
April 2 2013, Live Mint
This will discourage innovative drug discovery, Novartis MD Ranjit Shahani says
April 2, 2013, Times of India
Man behind Glivec hails SC verdict
April 2, 2013, Business Standard
Supreme Court Rejects Novartis Appeal; Upholds high standard for Section 3(d)
April 1, 2013, Lawyers Collective
Transplant girl: thank you for saving my life
April 1, 2013, The Telegraph
Novartis Loses Glivec Patent Battle in India
April 1, 2013, The Wall Street Journal
Novartis: India rejects patent plea for cancer drug Glivec
April 1, 2013, BBC News
Novartis cancer drug patent bid rejected by Indian court in landmark ruling
April 1, 2013, The Guardian
India's top court to deliver Novartis judgment
March 31, 2013, U.S. News & World Report
Gene Alfred Brothers
March 31, 2013 , Amarillo.com
Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia (DESTINY)
March 2013, National Cancer Institute
Indian pharma industry awaits SC verdict on Novartis patent claim on April 1
March 29, 2013, Indiatvnews.com
Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation:
prognostic relevance of the initial CD3+ T cel dose
March 29, 2013, Biol Blood Marrow Transplant
Low Volume Volatile Trading Likely Ahead Of Long Weekend
March 28, 2013, RTT News
Conditional EU approval for Pfizer's CML drug Bosulif
March 28, The Pharma Letter
Big Pharma waits nervously on India drug patent verdict
March 27, 2013, Reuters
New Monoclonal Antibody Targets Intracellular Oncogenic Proteins in Leukemias
March 26, 2013, Cancer Network
The 2013 Leukemia Ball Features Dana Carvey and Jim Belushi
March 25, 2013, Washingtontonian
Parents and Children's Hospital researchers await results on an experimental leukemia gene therapy
March 25, 2013, philly.com
European Panel Gives Nod to Leukemia Drug
March 25, 2013, Medscape Todqy News
East Coast Biotech Roundup: Moderna, bluebird, Blueprint
March 22, 2013, Xconomy
ARIAD Announces That Iclusig™ (Ponatinib) Receives Positive CHMP Opinion for Approval in the European Union
March 22, 2013, Fort Mill Times
Experimental Cancer Treatment Offers Hope VIDEO
March 21, 2013, ABCNews
Can Therapy With TKIs for CML Ever Be Stopped?
March 21, 2013, OncLIve
Researchers study use of dasatinib for patients with high-risk MDS
March 21, 2013, Medical Xpress
Cell-Based Immune Therapy Shows Promise in Leukemia Patients
March 20, 2013. Memorial Sloan-Kettering Cancer Center
Altered T-Cell Therapy Shows Promise from Acute Type of Leukemia
March 20, 2013, The New York Times
Mumbai company seeks cancer drug licence
Mar 19, 2013, The Times of India
Novartis' Life-Changing Blockbuster Drug
March 18, 2013, The Motley fool
Is the war on cancer an ‘utter failure’?: A sobering look at how billions in research money is spent
March 16, 2013, National Post
An Interview With Leo Ehrlich, Cellceutix CEO
March 14 2013, Seeking Alpha
Labceutics, Asuragen to jointly conduct pan European study on CML
March 13, 2013, Pharmaceutical Business Review
CML Stem Cell Burden at Diagnosis Associated With Treatment Outcomes
March 11, 2013, Cancer Network
Major new clinical trial to improve treatment for leukaemia patients
March 7, 2013, HealthCanal.com
Bosutinib Heads Toward Conditional Approval for CML in Europe
March 6, 2013 , Cancer Network
A World Without Cancer: Is Prevention the Cure?
March 6, 2013, The Motley fool
Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with
tyrosine kinase inhibitors
March 6, 2013, PublMed
Transplant advocate understands the need, personally
March 6, 2013, Atlanta Journal Constitution
Dasatinib thwarts brain cancer metastasis after bevacizumab use
March 1, 2013, Oncology Nurse Advisor
Why Are Investors Excited About Ariad?
February 28, 2013, Seeking Alpha
Novartis provides multimedia support to Rare Diseases Day
February 28, 2013, PMLiVE
Interest groups barrage Congress with sequester pleas
February 28, 2013, USA Today
Being chronically ill or in pain can feel like a full-time job
February 27, 2013, KevinMd.com
Canada: Pharma In Brief - Canada: Federal Court Upholds Validity Of GLEEVEC® Patent - See the decision
February 27, 2013, Mondaq
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib
February 26, 2013, PublMed
Lottie Duthu - loss of a CML warrior - See the Guest Book
February 25, 2013, CML2
New TKI Ponatinib Effective in Resistant CML
February 2013, Clinical Oncology News
After transplant, she's ready to get home
February 24, 2013, Omaha World-Herald
Bio-Path Shares are Attractive now - L-Grb-2 is a liposomal delivered antisense cancer drug that targets an multibillion dollar annual market for CML
February 22, 2013, Nasdaq
Leukemia arsenal has new drugs
February 22, 2013, Oncology Nurse Advisor
Lawsuit: Cancer patient didn't get medication at jail
February 21, 2013, The Salem News
From Chromosomes To Cures: The Lifesaving Cancer Research Of Dr. Janet Rowley VIDEO
February 21, 2013, Chicago Blood Cancer·
Memorial Sloan-Kettering scientist wins Breakthrough Prize in Life Sciences
February 21, 2013, News Medical
Court affirms utility of Gleevec patent
February 20 2013, Lexology
As CML Drugs Improve, Earlier Surrogate Outcome Markers Needed
February 20, 2013, Cancer Network
China sets up first CML molecular testing platform
February 20, 2013, China Daily
Targeting Leukemic Stem Cells in Marrow Could Stave Off TKI Resistance
February 19, 2013, Cancer Network
Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors
February 2013, American Journal of Hematology
Igniting the conversation about rare diseases
February 19, 2013, Palatka Daily News
The Philadelphia Chromosome by Jessica Wapner - Book Trailer Video
February 15, 2013, experimentpublishing
Show solidarity for International Childhood Cancer Day
February 15, 2013, Wort.lu
Leukemia, the first and second time around
February 15, 2013, HealthCanal
Use of Digital PCR Ramping Up
February 15, 2013, Gen
Living With Chronic Myeloid Leukemia
February 14, 2013, dailyRx
Epigenetic inactivation of the MIR129-2 in hematological malignancies
February 14, 2013, 7th Space
TalkPoint and FDAAdvisoryCommittee.com partner for series of FDA public workshops
February 13, 2013, PRWeb
Choosing a Tyrosine Kinase Inhibitor in CML
February 12, 2013, Targeted Healthcare
Couple fights leukemia together as they celebrate their first anniversary
February 11, 2013, MD Anderson Cancer Center
Cancer battle: Scientists engineer new tumor-killing virus
February 11, 2013, RT News
“Borne Out of Necessity and Data”: Conquering Mutations in Leukemia
February 6, 2013, PLOS Blog
Scene in Edmonds: The Edsel Hermoso Moscoso Mural (Donation to Max Foundation)
February 9, 2013, My Edmonds News
One Million Americans with Blood Cancer in Jeopardy of Losing Access to Needed Medications
February 6, 2013, PRNewswire
Raymore students help send ailing boy to Disney World
February 6, 2013, KCTV
Sandy and Tommy Edge, with their Valentine's tree in Baileyton
February 6, 2013, The Arab Tribune
Wilm’s Tumor Vaccine Effective for CML
February 5, 2013, Medical Automation
Chronic myeloid leukemia: Advances in diagnosis and management
February 5, 2013, Journal of the American Academy of Physician Assistants
Japanese Researchers Claim Detection Of Cancer-Causing Gene
February 5, 2013, RTTNews
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation
February 5, 2013, 7th Space
Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies
February 4, 2013, Blood Journal
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
February 4, 2013, Market Wire
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
February 1, 2013, Leukemia
Deaths from cancer have declined 20% over 20 years
January 31, 2013, Oncology Nurse Advisor
World cancer day – 2013 – Pat Garcia-Gonzalez VIDEO
January 30 2013, The Max Foundation
Sabutoclax (ONT-701) May BeThe Next Magic Bullet To Combat The Root Of Cancer
January 30 2013, Science 2.0
FDA Approves Imatinib (Gleevec) for Pediatric ALL
January 30, 2013, Cancer Network
“I Can’t Afford Any More Advances in Cancer Care, Doc!”
January 28, 2013, Cancer Network
Top Blood Cancer Team Joins NY-Presbyterian/Columbia
January 28, 2013, Newswise
IPO Preview: Stemline Therapeutics
January 28, 2013, Seeking Alpha
Targeted cancer treatment case study: 'I'm so grateful that I can live a normal life'
January 28, 2013, The Independant
Lanterns carry message of hope for fight against disease
January 25, 2013, The Independent.com
FDA approves Gleevec for children with acute lymphoblastic leukemia
January 25, 2013, FDA
Novartis pulls imatinib file in EU for hypertension
January 25, 2013, Pharma Times Online
Pan–BCL-2 Inhibition Sensitizes Leukemic Stem Cells to Kinase Inhibitors
January 24, 2013, Cancer Discovery
ARIAD prices $300M stock offering to support launch of leukemia drug
January 24, 2013, Boston Business Journal
C3G forms complexes with Bcr-Abl and p38alpha MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion
January 24, 2013, 7th Space
Helping healthy cells could be key to fighting leukaemia, research suggests
January 23, 2013, Imperial College London
CHMP Positive on Pfizers Bosutinib
January 23, 2013, Zacks.com
National Academy of Sciences Paper: Dartmouth researchers take novel approach to fighting treatment-resistant chronic myeloid leukemia
January 22, 2013, HeathCanal.com
Novartis return to growth in 2014, Vasella replaced by Reinhardt
January 22, 2013, PharmaTimes Online
Kareem Abdul-Jabbar joins Florida Forum series
January 22, 2013, Daily Record
The power of patents
January 22, 2013, Scienceline
10 Predictions That Will Transform Healthcare
January 22, 2013, Genetic Engineering News
Advances in treatment for chronic myelogenous leukaemia
January 22, 20131, South China Morning Post
Smart T Cell Vaccines: CAR T Cells - by Carl June, MD VIDEO
January 21, 2013, TheOncologistJournal
Flow synthesis for anticancer drug
January 21, 2013, RSC Advancing the Chemical Sciences
Pfizer gets CHMP backing for leukaemia drug bosutinib
Juanuary 21, 2013, PMLIve
Pfizer's Bosulif set for greater sales with EMA approval
January 18, 2013, Fierce Pharna
Sabutoclax appears to selectively target leukemia stem cells that are responsible for relapses
January 18, 2013, News Medical
Drug Targets Hard-To-Reach Leukemia Stem Cells Responsible for Relapses
January 18, 2013, Science Daily
Newly Founded Optum Labs will Analyze Big Data to Improve Patient are, Lower Costs of Care
January 18, 2013, HealthTechZone.com
Pfizer, Novartis win EU nods for new leukemia, eye drugs
January 18, 2013, FierceBiotech
Bosutinib in CML Cleared for Approval in Europe
January 18, 2013,, Medscape
Study: Enzyme Plays Important Role in CML Stem Cell Reprogramming
January 18, 2013, Cancer Network
Drug targets hard-to-reach leukemia stem cells responsible for relapses
January 17, 2013, Science Codex
Making Oncology History: Imatinib Pioneer Created His Own Opportunities
January 17, 2013, Onc LIve
Pat Has Conquered Cancer Twice - Offers Hints for the Rest of Us
January 16, 2013, About.com
Omacetaxine for Chronic or Accelerated Phase CML Patients with Resistance/Intolerance to Tyrosine Kinase Inhibitors
January 15, 2013, The ASCO Post
India to issue compulsory licences on Roche, B-MS drugs
January 15, 2013, PharmaTimet
Early molecular response may predict outcomes for nilotinib in CML
January 14, 2013, Healio
Double-unit cord blood transplants don't boost survival
January 14, 2013, The Oncology Report
Major new clinical trial to improve treatment for leukaemia patients
January 12, 2013, domain-b.com
Two-time Cancer Survivor's 10 Tips for the Healthcare System
January 12, 2013, Forbes
Bone Drug Kills Leukemia in Mice
January 11, 2013, BioScienceTechnology
Cancer gave us our vows meaning
January 8, 2013, Express.co.uk
ARIAD teams up with UK National Cancer Institute on leukemia treatment study
January 7, 2013, Boston Business Journal
The spirit of Star Trek
January 7, 2013, MPRnews
ARIAD and the U.K. National Cancer Research Institute to Collaborate on SPIRIT 3 Clinical Study
January 7, 2013, Pharma Live
Journey of CML - 17th Congress of EHA VIDEO
January 4, 2013, communicationEHA
Patrick signs bill requiring oral cancer drug coverage, over business groups' opposition
January 4, 2013, Boston Business Journal
Sorry, but there's no such thing as a diet that cures cancer
January 1, 2013, Mail Online
DNA vaccine for leukemia has early positive results
January 1, 2013, Oncology Nurse Advisor
=============================================================
2012
=============================================================
A new enzyme that contributes to the proliferation of leukemia is discovered
December 26, 2012, Private MD News
DNA-repair problems destroy hardy leukemia cells
December 26, 2012, OncologyNurseAdvisor
Latest Treatment and Research for Chronic Myeloid Leukemia
December 24, 2012, Cancer Network
Parthenolide eliminates leukemia initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic
leukemia
December 20, 2012, Blood Journal
Can we safely stop TKI therapies? Experience from the STOP trials VIDEO
Dr. Delphine Rea, Hôpital Saint-Louis, Paris, France
December 2012, iCMLf
Options increase for CML patients failed by existing drugs
December 21, 2012, EurekAlert
Ponatinib Could Herald “Revolution”in CML Treatment
December 20, 2012, OncLive
Bosutinib a New Option for Chronic Myeloid Leukemia
December 2012, Clinical Oncology
New group CML Life – Africa on Facebook
December 20, 2012, CMLeukemia
New group CML Tunisia on Facebook
December 20, 2012, CMLeukemia
Choosing a Tyrosine Kinase Inhibitor in Chronic Myelogenous Leukemia
December 19, 2012, OncLive
When it comes to treating his CML, Kareem Abdul-Jabbar shoots and scores
December 18, 2012, JSOnline
Ariad's Wonder Drug For Leukemia Patients
December 17, 2012, Seeking Alpha
Drug Approved To Treat Rare Forms Of Leukemia
December 16, 2012, Medical News Today
New Leukemia Rx Hits Market
December 14, 2012, dailyRx
OHSU-developed ponatinib wins FDA approval
December 14, 2012, Portland Business Journal
FDA Approves Ponatinib to Treat Leukemia
December 14, 2012, Cancer Network
FDA grants approval for potential‘blockbuster’ leukemia drug made
by Cambridge-based Ariad
December 14, 2012, Boston.com
F.D.A. Gives Early Approval to Drug for Rare Leukemia
December 14, 2012, The New York Times
ARIAD Announces Accelerated Approval by FDA of Iclusig (Ponatinib) for Patients with CML and Ph+ ALL Resistant or Intolerant to Prior Tyrosine Kinase Inhibitor Therapy
December 14, 2012, Ariad
FDA Approves Ariad Pharma Leukemia Drug
December 14, 2012, The Street
The prognosis for chronic myeloid leukaemia dramatically improved over time
December 12, 2012, Doctor Tipster
TKI-resistant human leukemia stem cells are the source of genomic instability
December 12, 2012, News Medical
Abstracts and notes on CML presentations - ASH 2012 Atlanta
December 11, 2012, CMLsupport
ASH: Updated PACE Findings Uphold Ponatinib Benefit in CML and Ph+ ALL
December 11, 2012, Cancer Network
ASH: Higher Imatinib Exposures Associated with Better Chronic-Phase CML Outcomes
December 11, 2012, Chemotherapy advisor
Learning about CML
December 11, 2012, Cure Today
Ariad reports most patients cancer-free after 1 year in ponatinib study
December 11, 2012, Atlanta Business Journal
Ponatinib Works in CML When Nothing Else Is Effective
December 11, 2012, Medscape Today
Drug resistant leukemia stem cells may be source of genetic chaos, Temple scientists find
December 11, 2012, Science Codex
Fatigue Is the Major Aspect Compromising Health-Related Quality of Life of Chronic Myeloid Leukemia Patients Receiving
Long-Term Imatinib Therapy
December 10, 2012, ASH 2012
Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
December 10, 2012, ASH2012
A 7-year-old pixie named Emily Whitehead has erased any remaining doubts about the power of a University of Pennsylvania gene therapy to eradicate certain blood cancers.
December 10, 2012, philly.com
In Girl’s Last Hope, Altered Immune Cells Beat Leukemia
December 10, 2012, CBS Philly
Ariad rises on positive leukemia drug results
December 10, 2012, Boston Herald.com
In Girl’s Last Hope, Altered Immune Cells Beat Leukemia
December 9, 2012, The New York Times
Temple scientists target DNA repair to eradicate leukemia stem cells
December 9, 2012, MedicalXpress
Ariad drug proves effective in curbing chronic leukemia in study
December 9, 2012, Reuters
RAD52-Dependent Synthetic Lethality Eradicates Leukemia Stem Cells
December 9, 2012, ASH 2012
Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders
December 9, 2012, Science Codex
ASH 2012: Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia
December 9, 2012, ecancernews
Is going for cure in chronic myeloid leukemia possible and justifiable?
December 8, 2012, Hematology
Winning the Battle Against Leukemia: Positive Early Results in Clinical Trial for DNA Vaccine
December 7, 2012, Science Daily
Ponatinib offers new hope in drug-resistant leukemia
December 5, 2012 , News-Medical.net
What's Hot at ASH This Year?
December 3, 2012, Medscape Today
In CML, Next-Generation TKIs Aim to Boost Outcomes
November 30, 2012, Onc LIve
Ponatinib for Chronic Myeloid Leukemia
November 29, 2012, The New England Journal of Medicine
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
November 29, 2012, The New England Journal of Medicine
Ponatinib thwarts T315I gene mutation in chronic myeloid leukemia
November 29, 2012, News Medical
Ponatinib for Chronic Myeloid Leukemia
November 29, 2012, The New England Journal Of Medecine
Ponatinib acts against the most resistant types of chronic myeloid leukemia
November 28, 2012, MD Anderson News
Attacking Leukemia Resistance
November 28, 2012, dailyRx
Drug (Ponatinib) Shows Potential in Leukemia
November 28, 2012, Medpage Today
Ponatinib acts against the most resistant types of chronic myeloid leukemia
November 28, 2012, Science Codex
Ponatinib Acts Against the Most Resistant Types of Chronic Myeloid Leukemia
November 28, 2012, Science Daily
Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
November 28, 2012, Reuters
Model-based decision rules reduce the risk of molecular relapse after cessation of tyrosine kinase inhibitor therapy in chronic myeloid leukemia
November 21, 2012, Journal Blood
BELA: Bosutinib No Better Than Imatinib in Newly Diagnosed CML
November 19, 2012, Cancer Network
Successful treatment of nilotinib-induced pleural effusion with prednisone.
November 15, 2012, PublMed
Nilotinib-Resistant CML Cells Show Abnormal Expression of Several Genes, Suggests Therapeutic Targets
November 15, 2012, Cancer Network
Novartis Provides R&D Update - Analyst Blog
November 15, 2012, Nasdaq
ARIAD Pharmaceuticals' CEO Presents at Lazard Capital Markets Healthcare Conference (Transcript)
November 15, 2012, Seeking Alpha
Leukaemia drug can help treat lymphoma
November 14, 2012, Cambridge News
Can Ariad Survive on 2 Drugs?
November 13, 2012, Motley Fool
Research and Markets: Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2012 Update
November 13, 2012, HeraldOnline.com
Ariad: A Very Interesting Biotech With An Even More Promising Pipeline
November 13, 2012, Seeking Alpha
Rwanda: Scientists Call for More Research On Leukemia
November 13, 2012, allAfrica.com
Leukaemia 'wonder drug' could be used to treat range of blood cancers
November 12, 2012, HealthCanal.com
Your Immune System 101: Introduction to Clinical Immunology VIDEO
November 11, 2012, UCtelevision
Novartis Future Growth Prospects Secured by Industry-leading Pipeline, with More than 139 Projects with 73 New Compounds -Tasigna: "Path to Cure" - a potential paradigm shift in CML treatment
November 9, 2012, PharmaLIve
Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects.
November 8, 2012, PublMed
Ariad CEO discusses company’s battle against cancer
November 8, 2012, Boston Herald
CML: the good, the better, and the difficult choices
November 8, 2012, Journal Blood
Switching Therapy Following Suboptimal Response in Chronic Myelogenous Leukemia
November 7, 2012, OncLive
BioLineRx Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 ASH Annual Meeting
November 7, 2012, Market Watch
Doctor still knows best
November 5, 2012, Chron
Column: Disabled-sports mentor leader we can get behind
November 2, 2012, azcentral.com
Imatinib mesylate effectively treats children with neurofibromatosis type 1 tumorsUpcoming ASCO Meeting Could Move These Stocks
April 4, 2012. Seeking Alpha
Piramal to present data on its three IND candidates at AACR annual meeting in Chicago
April 4, 2012, Pharmabiz.com
ARIAD: Xiaotian Zhu on Ponatinib
April 3, 2012, Executive video
Research and Markets: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2012
April 2, 2012, Business Wire
Clinical Conundrums - quiz for the community hematologist/oncologist
March 2012, Clinical Oncology
Leukemia Drug Fails Mesothelioma Trial
March 31, 2012, Surviving Mesothelioma
New inhibitors of a cancer-causing protein may lead to targeted therapeutics
March 29, 2012, Physorg.com
Novartis versus India patent case postponed to July 10
March 29, 2012, Pharma Times
Myeloid Malignancies Underreported In U.S
March 28, 2012, Newswise
One in a Million – Children with CML
March 28, 2012, Petaluma Patch
Study in JAMA reports significant survival benefit in certain GIST patients taking Novartis drug GlivecR for three years after surgery
March 27, 2012,Reuter
"NICE" news for Novartis CML drugs, but not for Bristol-Myers
March 22, 2012, Pharma Letter
It’s In The Genes: East Asians More Likely To Be Resistant To Some Cancer Drugs
March 21, 2012, Asian Scientist
Genetic Variation in East Asians Found to Explain Resistance to Cancer Drugs
March 18, 2012, Science Daily
Ohio legislator wants insurance coverage to be same for oral, injectable chemotherapy treatments
March 17, 2012, Cleveland.com
Scientists map genetic evolution of leukemia
March 14, 2012, Medical Xpress
Indian Supreme Court to Rule on Gleevec Patent
March 12, 2012, Patent Docs
Indian Supreme Court to Rule on Gleevec Patent
March 12, 2012, Patent Docs
Lisa Velasco: Managing CML With A Husband's Strong Support VIDEO
March 11, 2012, Patient Power
Pfizer Looks Set To Dominate With Takeovers
March 9, 2012, Seeking Alpha
Insights into early child hood leukemia - Early T cell precursor acute lymphoblastic leukemia has myeloid aspects
March 8, 2012, daily RX
Imatinib helpful after interferon fails in CML treatment
March 8, 2012, OncologyNurseAdvisor
Planned Pregnancy in CML Patient in Molecular Remission
March 6, 2012, Hindawi
Pain is more Painful in Poor Place - Chronic pain tougher to manage for young patients
Mar 6, 2012, Daily Rx
India’s Supreme Court to Hear Dispute on Drug Patents
March 6, 2012, The New York Times
Ariad Pharmaceuticals - Much to live up to
March 5, 2012, Edison Investment Research
I won my cancer battle thanks to wonder drug
March 2, 2012, Weekly News
Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR–ABL inhibitors as first-line therapy
February 2012, Leukemia
Myelofibrosis Drug Shrinks Symptoms
February 29, 2012, Medpage Today
Cancer: Solving an age-old problem
February 29, 2012, Nature
Leukemia Survival Up with Gleevec
February 29, 2012, MedPage Today
Cancer drugs could halt Ebola virus
February 29, 2012, MSN News
Blood ambassadors
February 29, 2012, Goulburn Post
Drug Helps Leukemia Patients Live Longer
February 29, 2012, Ivanhoe
Ten-Year CML Survival Estimate of 68 Percent With Imatinib
February 28, 2012, OncologyNurseAdvisor
EU approves new label for Novartis drug Glivec extending adjuvant therapy to 3-years for certain GIST patients
February 28, 2012, Pharmabiz.com
Imatinib Effective in CML Patients Who Failed Interferon
February 27, 2012, Medscape Today
Dr. Erba Describes Proper Diagnostic Testing of CML VIDEO
February 27, 2012, Onc Live
Managing Chronic Myeloid Leukemia Treatment
February 27, 2012, Onc Live
CML patients can benefit from imatinib after unsuccessful interferon therapies
February 27, 2012, News-Medical.net
Novartis' Glivec extends European GIST licence
February 27, 2012, PMLiVE
Novartis explains stance over India patent law challenge
February 27, 2012, Pharma Times Online
Blocking the Blockers – CML stem cell enzyme may become new target
February 26, 2012, Daily RX
Novartis again urged to drop India patent lawsuit
February 24, 2012, PharmaTimes Online
Montrealer looking for a bone marrow hero Julie Ouimette
- February 23, 2012, CTV.ca
Gleevec reformulated eliminates morphine tolerance in animal study
February 20, 2012, dailyRx
Bone Marrow Drive Held For Local Firefighter
February 16, 2012, News.com
Francis Collins: 3 Scientific Breakthroughs Changing Medicine VIDEO
February 15, 2012, Medscape
Ariad wins key patent for leukemia drug
February 15, 2012, The Boston Globe
Hematologic Cancers in Pregnancy Pose Substantial Risks
February 14, 2012, Medscape
Seattle's Sage Bionetworks seeks a drug-discovery revolution
February 13, 2012, The Seattle Times
Ariad's stock jumps on drug sales projection
February 13, 2012, Boston Business Journal
Therapy targets leukemia stem cells
February 13, 2012, Eurekalert
In-vivo proof of concept in malignant melanoma
February 9, 2012, Reuters
Outwitting Chronic Myeloid Leukemia
February 9, 2012, DailyRx
Can The Man From Heinz Keep Novartis On Top?
February 8, 2012, Forbes
Bio-Path completes second cohort dosing of leukemia drug trial
February 8 , 2012, Pharmaceutical Business Review
Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial
February 7, 2012, Haematologica
Gleevec wins wider approval for use in GI cancer
February 7, 2012, OncologyNurseAdvisor
Kareem: Back-to-basket centers gone
February 4, 2012, ESPN LA
Benzene Leukemia Lawsuit Filed Over Hazardous Workplace
February 3, 2012, Injuryboard
Funding the NIH: Investing in medical research is vital to our health
February 3, 2012, Oregon.Live
Penn State: Inspiring Collaboration VIDEO
February 2, 2012, Penn State
Gleevec indications expanded to include rare cancer
February 2, 2012, The Clinical Advisor
Dreams still come true - Cancer survivor gives back to sick child through organization
February 1, 2012, The advocate
FDA Approves Label Change Recommending Three Years of Novartis' Glivec After GIST Surgery
February 1, 2012, GEN
Phase 1 Clinical Trial of KB004 in EphA3-Expressing Hematologic Malignancies
January 2012, Monash University
2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012
January 31, 2012, Seeking Alpha
Tasigna Recommended as Second-line CML Therapy - Tasigna receives final recommendation from NICE
January 30, 2012, DailyRx
Candid Cancer segment - what to know about getting a second opinion. VIDEO
January 29, 2012,A wider world
CML Update at ASH 2011 - Interview with Elias Jabbour, M.D. VIDEO
January 27, 2012, OncUViewTV
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ CML
January 26, 2012, Pfizer
For CML, Nilotinib Superior to Imatinib at 24 Months
January 26, 2012, Clinical Oncology
Bristol-Myers Misses Analyst Estimates as Costs Increase to Gain New Drugs
January 26, 2012, Bloomberg
Bill introduced to allow cancer patients access to easier, more affordable chemo
January 25, 2012, WGMD.com
Kareem Abdul-Jabbar – In His Own Words
January 25, 2012, Coping with cancer
HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells
January 24, 2012, Journal Blood
Brian Druker wins prestigious Japan Prize
January 24, 2012, Portland Business Journal
Marathon Against CML Still Not Won
January 24, 2012, DailyRx
EMA adopts positive opinion to update Novartis Glivec label to include 3- year treatment for GIST patients after surgery
January 23, 2012, Pharmabiz.com
Analysis of outcomes in adolescents and young adults with CMLtreated with upfront tyrosine kinase inhibitor therapy
January 22, 2012,Heamatologica
Clinical cardiac safety profile of nilotinib.
January 22, 2012, PubLMed
Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.
January 20, 2012, International Journal of Hematology
Research and Markets: Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011
January 19, 2011, Business Wire
Analyst: Red-hot Ariad is a possible acquisition target
January 19, 2012, Business journal
Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+chronic myeloid leukemia progenitors preserving normal stem cells
January 18, 2012, Journal Blood
Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives
January 15, 2012, PubLMed
Continuing Good News for Chronic Myeloid Leukemia Patients
January 13, 2012, Cancer Network
Condolences to the family of Zavie Miller
January 9, 2012, CML World
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
January 6, 2012, Journal Blood
TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
January 3, 2012, PRNewswire
Afghans’ free treatment: Health dept fears audit objections
January 2, 2012, Dawncom
